Role of surgery in patients with early stage small-cell lung cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Che K, Shen H, Qu X, et al. Survival outcomes for patients with surgical and non-surgical treatments in stages I-III small-cell lung cancer. J Cancer. 2018;9:1421–1429. doi:10.7150/jca.2358329721052
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2007;2:1067–1077. doi:10.1097/JTO.0b013e31815bdc0d18090577
   PubMed Web of Science ®Google Scholar
• Almquist D, Mosalpuria K, Ganti AK. Multimodality therapy for limited-stage small-cell lung cancer. J Oncol Pract. 2016;12:111–117. doi:10.1200/JOP.2015.00906826869647
   PubMed Web of Science ®Google Scholar
• Inoue M, Miyoshi S, Yasumitsu T, et al. Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. Ann Thorac Surg. 2000;70:1615–1619.11093496
   PubMedGoogle Scholar
• Rostad H, Naalsund A, Jacobsen R, et al. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy? Eur J Cardiothorac Surg. 2004;26:782–786. doi:10.1016/j.ejcts.2004.06.01115450573
   PubMed Web of Science ®Google Scholar
• Brock MV, Hooker CM, Syphard JE, et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: its time has come. J Thorac Cardiovasc Surg. 2005;129:64–72. doi:10.1016/j.jtcvs.2004.08.02215632826
   PubMed Web of Science ®Google Scholar
• Lim E, Belcher E, Yap YK, Nicholson AG, Goldstraw P. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol. 2008;3:1267–1271. doi:10.1097/JTO.0b013e318189a86018978561
   PubMed Web of Science ®Google Scholar
• Schneider BJ, Saxena A, Downey RJ. Surgery for early-stage small cell lung cancer. J Natl Compr Canc Netw. 2011;9:1132–1139.21975913
   PubMed Web of Science ®Google Scholar
• Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet. 1973;2:63–65. doi:10.1016/s0140-6736(73)93260-14123619
   PubMed Web of Science ®Google Scholar
• Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618–1624. doi:10.1056/NEJM1992120332723021331787
   PubMed Web of Science ®Google Scholar
• Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992;10:890–895. doi:10.1200/JCO.1992.10.6.8901316951
   PubMed Web of Science ®Google Scholar
• Lewiński T, Zuławski M, Turski C, Pietraszek A. Small cell lung cancer I–III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy. Eur J Cardiothorac Surg. 2001;20:391–398. doi:10.1016/s1010-7940(01)00787-411463563
   PubMed Web of Science ®Google Scholar
• Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg. 2005;129:977–983. doi:10.1016/j.jtcvs.2004.05.03015867769
   PubMed Web of Science ®Google Scholar
• Schild SE, Bonner JA, Hillman S, et al. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). J Clin Oncol. 2007;25:3124–3129. doi:10.1200/JCO.2006.09.960617634491
   PubMedGoogle Scholar
• Chen J, Jiang R, Garces YI, et al. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010;67:221–226. doi:10.1016/j.lungcan.2009.04.00619497635
   PubMed Web of Science ®Google Scholar
• Shields TW, Higgins GA Jr, Matthews MJ, Keehn RJ. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1982;84:481–488.6289013
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Ginsberg RJ, Patterson GA, Evans WK, Feld R. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg. 1989;97:177–186.2536868
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Ginsberg RJ, Feld R, Evans WK, Johansen E. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg. 1991;101:385–393.1847981
   PubMed Web of Science ®Google Scholar
• Eberhardt W, Stamatis G, Stuschke M, et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer. 1999;81:1206–1212. doi:10.1038/sj.bjc.669083010584883
   PubMed Web of Science ®Google Scholar
• Lüchtenborg M, Riaz SP, Lim E, et al. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009. Thorax. 2014;69:269–273. doi:10.1136/thoraxjnl-2013-20388424172710
   PubMed Web of Science ®Google Scholar
• Schreiber D, Rineer J, Weedon J, et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer. 2010;116:1350–1357. doi:10.1002/cncr.2485320082453
   PubMed Web of Science ®Google Scholar
• Yu JB, Decker RH, Detterbeck FC, Wilson LD. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol. 2010;5:215–219. doi:10.11097/JTO.0b013e3181cd320820101146
   PubMed Web of Science ®Google Scholar
• Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, DeCamp MM. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis. J Thorac Cardiovasc Surg. 2011;142:538–546. doi:10.1016/j.jtcvs.2010.11.06221684554
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhou Z, Xue Q, Zhang X, He J, Wang L. Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute. Eur J Cancer Care (Engl). 2013;22:789–796. doi:10.1111/ecc.1208223763282
   PubMed Web of Science ®Google Scholar
• Yokouchi H, Ishida T, Yamazaki S, et al. Prognostic impact of clinical variables on surgically resected small-cell lung cancer: results of a retrospective multicenter analysis (FIGHT002A and HOT1301A). Lung Cancer. 2015;90:548–553. doi:10.1016/j.lungcan.2015.10.01026604032
   PubMed Web of Science ®Google Scholar
• Leuzzi G, Lococo F, Alessandrini G, et al. Prognostic impact of node-spreading pattern in surgically treated small-cell lung cancer: a multicentric analysis. Lung. 2017;195:107–114. doi:10.1007/s00408-016-9954-427738827
   PubMed Web of Science ®Google Scholar